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Abstract
Background: Arterial aging is well characterized in industrial populations, but scantly described in populations with little
access to modern medicine. Here we characterize health and aging among the Tsimane, Amazonian forager-horticulturalists
with short life expectancy, high infectious loads and inflammation, but low adiposity and robust physical fitness.
Inflammation has been implicated in all stages of arterial aging, atherogenesis and hypertension, and so we test whether
greater inflammation associates with atherosclerosis and CVD risk. In contrast, moderate to vigorous daily activity, minimal
obesity, and low fat intake predict minimal CVD risk among older Tsimane.
Methods and Findings: Peripheral arterial disease (PAD), based on the Ankle-Brachial Index (ABI), and hypertension were
measured in Tsimane adults, and compared with rates from industrialized populations. No cases of PAD were found among
Tsimane and hypertension was comparatively low (prevalence: 3.5%, 40+; 23%, 70+). Markers of infection and inflammation
were much higher among Tsimane than among U.S. adults, whereas HDL was substantially lower. Regression models
examine associations of ABI and BP with biomarkers of energy balance and metabolism and of inflammation and infection.
Among Tsimane, obesity, blood lipids, and disease history were not significantly associated with ABI. Unlike the Tsimane
case, higher cholesterol, C-reactive protein, leukocytes, cigarette smoking and systolic pressure among North Americans are
all significantly associated with lower ABI.
Conclusions: Inflammation may not always be a risk factor for arterial degeneration and CVD, but instead may be offset by
other factors: healthy metabolism, active lifestyle, favorable body mass, lean diet, low blood lipids and cardiorespiratory
health. Other possibilities, including genetic susceptibility and the role of helminth infections, are discussed. The absence of
PAD and CVD among Tsimane parallels anecdotal reports from other small-scale subsistence populations and suggests that
chronic vascular disease had little impact on adult mortality throughout most of human evolutionary history.
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Introduction
We report the first systematic study of peripheral arterial disease
(PAD), hypertension and cardiovascular risk factors in a population
with both high infectious and parasitic burden but low adiposity and
robust physical fitness. The Tsimane are a population of 9,000
forager-horticulturalists in the Bolivian Amazon. Their recent life
expectancy at birth of 43 years resembles much of Europe in the mid-
nineteenth century, with half of documented deaths by infectious and
parasitic disease [1]. The Tsimane have only in the past decade
begun an epidemiological transition to increased life expectancy.
Public health infrastructure and medical services remain minimal for
most Tsimane and they continue to incur high rates of infection.
Immunization was only regularly administered in the past decade and
is still sporadic in many areas. Medical surveys show that about one-
third suffer from respiratory illness, one-fourth from gastrointestinal
illness, and over three-fourths from intestinal helminths or pathogenic
protozoa. Anemia is highly prevalent and physical growth is stunted.
Their history of infection and chronic low-grade inflammation lead us
to predict greater PAD and hypertension.
Prevalence of PAD and hypertension was measured in Tsimane
adults and compared with representative samples from seven
countries spanning the Americas, Asia, Africa and Europe. PAD
was assessed with the Ankle-Brachial Pressure Index (ABI), a
simple, non-invasive and recommended form of PAD diagnosis [2]
and risk indicator of coronary heart disease, stroke and mortality
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[3,4,5,6]. We use regression models to examine associations of ABI
and blood pressure with cholesterol, triglycerides, and body mass
index (BMI) (measures of energy balance) and with biomarkers of
inflammation [C-reactive protein (CRP)] and infection [erythro-
cyte sedimentation rate (ESR), leukocytes (WBC)]. We present
comparative analyses among U.S. adults using a large, nationally
representative sample (NHANES) in order to highlight the
distinctions between Tsimane and members of a sedentary, well-
fed and low infection population.
Background and Significance
Cardiovascular disease (CVD) and stroke account for the
majority of adult deaths in the industrialized world, and are now
major causes of morbidity and mortality in the developing world
[7]. In the U.S., atherosclerosis is the main cause of CVD-related
heart attacks and strokes [8]. PAD, affecting limb circulation in 10
million Americans, is primarily caused by atherosclerosis and is a
risk indicator for coronary and carotid arterial disease, aneurysm,
diabetes, and hypertension [9]. Diagnosis of PAD increases risk of
CVD mortality 4–6 times over healthy age-matched individuals,
though PAD is often asymptomatic [6]. The prevalence of PAD is
10–25% in men and women over 55 in developed countries.
Recent research considers chronic inflammation in the onset and
progression of CVD. Many studies associate inflammatory markers
and CVD morbidity and mortality after controlling for risk factors
[8,10,11]. Bacterial, viral and parasitic infections are common among
traditional human and primate populations both now and through-
out our evolutionary past [12]. As a consequence, inflammation and
adaptive immune responses have evolved under intense selection
against pathogens. However, in modern societies with immuniza-
tions, public sanitation, adequate nutrition and medical services, and
where hypertensive people live sedentary lives and frequently smoke,
inflammatory processes have been implicated in all stages of arterial
aging and atherogenesis [10,11], beginning early in life [10,13], and
in the critical CVD risk factor, hypertension [14].
Atherosclerosis and CVD are caused by a complex interaction
of lifestyle factors (diet, energy balance, smoking, exercise) and
inflammatory pathways. Elevated cholesterol and other risk factors
predict less than half of heart attacks annually [15]. The acute
phase inflammatory marker, C-reactive protein (CRP), often
predicts future vascular events better than other risk factors
[16,17]. Indeed, individuals with lower than average cholesterol
but high CRP have fewer heart attacks when given statins [18]. An
estimated 25–30 million Americans fall into this category of low
cholesterol but high CRP. Although CRP’s role either as
inflammatory marker or causal agent of vascular disease continues
to be a subject of lively debate [19,20,21], it is increasingly used in
clinical settings to help evaluate CVD risk.
Understanding the interaction of diet, energy balance, physical
activity and inflammation is hampered by the populations studied:
mainly well-fed in developed nations, or experimental animals fed
ad libidum on diets that promote rapid growth. Both biomes contain
few infectious pathogens and environmental inflammogens. In
contrast, past human populations faced environments with
strenuous physical demands, greater pathogen burden and low
caloric diets. These environments characterize the lives of extant
indigenous peoples with traditional lifestyles. Much of total
mortality in those environments is by infections and parasites,
rather than by the causes common in industrial populations, like
chronic heart disease, diabetes and cancer [15,22]. Thus, opposing
risk conditions characterize such populations. On one hand, high
infection rates over the life course should associate with greater
lifetime inflammation exposure, and hence greater risk of
atherosclerosis and CVD. On the other hand, high work effort,
minimal obesity, and low fat intake should lower CVD risk.
Though arterial aging in the form of elastin fragmentation and
medial fibrosis may be an inevitable outcome of aging, the role of
atherosclerosis in adult morbidity before the 20th century remains
unclear. Studying arterial disease and CVD in indigenous
populations is illuminating for three reasons. First, new light is
shed on the roles and interactions of diet, exercise and
inflammation on disease etiology. Second, subsistence populations
with minimal medical access are characteristic of our evolutionary
past, and may be informative about the role of vascular disease in
the biology of aging during the long course of human evolution.
Third, infectious disease is most prevalent in tropical regions of the
developing world where the synergistic mix of risk factors and
infectious causes are expected to bring a ‘‘gigantic epidemic of
heart disease’’ in the coming decades [23].
Existing research provides contradictory findings and lacks
important information on relevant variables. Traditional popula-
tions often show negligible CVD prior to acculturation to western
diets and sedentary lifestyles [22,24,25]. Recently, however,
Australian Aborigines and Pima Indians have acquired the highest
prevalence of obesity and Type 2 diabetes in the world [26].
Higher rates of atherosclerosis, heart murmurs and other cardiac
conditions among US soldiers in early 20th century were linked to
higher lifetime burden of infectious disease, particularly respira-
tory infections and rheumatic fever [27]. In one of the few non-
western populations assessed for PAD, high prevalence was found
among black South Africans [28], consistent with their extensive
CVD mortality and morbidity. To date, no studies have measured
the prevalence of PAD and other cardiovascular risk factors, such
as hypertension, in an environmental context with chronically low
energy status and high rates of infection.
Results
Prevalence of CVD: PAD and BP
Peripheral arterial disease (PAD). PAD is absent
(ABI,0.9) among all 258 Tsimane in our sample (see Methods).
Mean6SD ABI is 1.1060.07 for Tsimane women and 1.1660.07
for men over age 40 (Fig. 1a). There is little evidence that ABI
changes by age among Tsimane.
The absence of PAD among Tsimane contrasts with patterns
observed in national samples, especially South African blacks
(Fig. 2a). PAD increases with age in every investigated population
except the Tsimane, ranging from 5–25% for adults over age 70.
The comparison includes people in developed and developing
countries, in urban and rural settings, but none live in the
relatively isolated and infected conditions of the Tsimane.
Blood pressure (BP). Systolic BP was low among Tsimane
young adults and climbed to moderately higher values among older
adults (Fig. 1b). From age 20 to 70, the mean increases by 16% for
women and 3% for men. Average diastolic BP is 9% higher for
women in their 70s (6568 mm) than for those in their 20 s, and 6%
higher for older men than the average 66610 for men in their 20 s
(Table 1). Overall prevalence of hypertension among adults $20
years is 3.5% (SBP$140 and/or DBP$90), and increases with age.
Hypertension peaks at 23.5% (12/51) for adults .70 years, much
lower than that of the US and other countries (Fig. 2b).
CVD risk factors: inflammatory markers, infectious disease
and blood lipids
Inflammatory markers and disease risk. Blood indicators
suggest high levels of inflammation and infection among Tsimane
(Fig. 3, Tables 1 and 2). For adults aged 40+, mean6SD CRP is
Arterial Aging among Tsimane
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8.5617.8 mg/L. About 50% of adults 40+ have CRP levels
indicating CVD risk (CRP$3.0 mg/dL) and 23% have CRP
levels $10.0 mg/dL, which is usually indicative of acute infection
[mean6SD CRP (,10.0 mg/dL) is 2.762.4] Tsimane white
blood cell counts are elevated by US norms: with an average
9,46162,824 units/mm3, 17% over 40 are elevated. The
prevalence of elevated ESR is 82% (see Table 1).
Tsimane clinical history is consistent with high cumulative
exposure to acute infection. About 55% of those 40+ had at least
one gastrointestinal illness in two prior medical exams and one third
had respiratory illnesses. Two-thirds carried helminthic parasites.
Infection and concomitant high inflammation are prevalent [29].
Blood lipids. Other CVD risk factors are low: mean6SD
total cholesterol, 138629 mg/dL and LDL, 75622 mg/dL.
However, high density lipoprotein (HDL) and triglycerides are
exceptions: HDL is low at 3769 mg/dL and trigylcerides
moderately high at 130673 mg/dL. Over half of Tsimane
adults show unfavorable HDL levels by American Heart
Association standards (,40 for men, ,45 for women). Whereas
no Tsimane show high risk levels of total cholesterol and LDL,
20% of U.S. adults have elevated levels of each blood lipid, even
though many Americans use lipid-lowering medications. The
prevalence of high triglycerides for most age groups in the U.S. is
Figure 1. Median and interquartile values of (A) ABI (averaged
across left and right sides), (B) systolic BP and (C) diastolic BP,
for Tsimane by age group and sex.
doi:10.1371/journal.pone.0006590.g001
Figure 2. Prevalence of (A) Peripheral Arterial Disease
(ABI,0.9) and (B) Hypertension (SBP$140 and/or/
DBP.290), among Tsimane and other populations. Data
sources for ABI: urban China [67], urban Mexico [68], South Africa
[28], southeast Spain [69], Sweden (Sigvant Birgitta pers comm),
Thailand [70], United States [9]. Hypertension data for the same
countries come from the World Health Organization Global Infobase,
http://www.who.int/infobase/report.aspx. Note: x-axis represents mid-
points of age intervals because of the different age intervals reported
among studies (e.g. 30–39 vs. 35–44); Hypertension defined as
SBP$140 and/or DBP$90 except for Sweden where SBP$160 and/or
DBP$95.
doi:10.1371/journal.pone.0006590.g002
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double that of the Tsimane. There is little indication of age
increases in these measures among Tsimane. Values are similar
across ages after 40 and do not show increased CVD risk at older
ages in any parameter (Fig. 3, Table 1).
Lifestyle risk factors: obesity and smoking
Obesity is 8–10 times more common in the US than among
Tsimane (Tables 1 and 2). The average BMI for Tsimane adults is
24, but 29 for US adults. Among Tsimane tobacco consumption is
minimal, about 0.7761.85 pack years for men and 0.1460.78 for
women. While 72% of Tsimane men and 14% of women reported
occasional use of unfiltered cigarettes or tobacco from home
gardens, most Tsimane even in their sixties have smoked less than 2
pack-years. By contrast, U.S. adults aged 60+ have smoked 24 (men)
and 11 (women) years.
Summary
The main CVD risk factors greater among Tsimane than U.S.
adults are markers of infection. Low HDL prevalence is also
common, being about 3-fold greater among Tsimane, although the
clinical significance of low HDL in energy-limited populations has
not been established. Inflammatory markers (CRP, ESR, and WBC
counts) were significantly higher among Tsimane (Tables 1 and 2).
Regressions of ABI and BP on risk factors. The links
between CVD risk factors and ABI, SBP and DBP were examined
in multiple regressions controlling for age, age2 and gender in both
Tsimane and U.S. populations to explore whether risk factors
show similar associations in both populations.
ABI. Regression results indicate that Tsimane men have
higher ABI than women (Table 3), in contrast to the patterns for
U.S. men and women. Obesity (BMI$30), blood lipids, disease
history, and cardiovascular indicators were not significantly
associated with Tsimane ABI after controlling for age and sex
(Table 3). Higher ESR predicted lower ABI (increase by 10 mm/
hr associated with decrease in ABI of 0.05). Those with higher
brachial diastolic BP display lower ABI. In U.S. adults, unlike the
Tsimane case, higher cholesterol, CRP, WBC count, cigarette
smoking and systolic pressure are all significantly associated with
lower ABI, or more PAD (Table 3). Combining BMI, CRP,
cholesterol and cigarette smoking in the same regression (Table 4)
does not change these results. Restricting CRP analyses to cases
where CRP,10 mg/L, as recommended by the American Heart
Association and Centers for Disease Control [30], does not change
the Tsimane results, although in the U.S. the magnitude of the
effect increases five-fold (b= -0.005, p,0.001).
SBP and DBP
Aside from sex, the strongest predictor of both SBP and DBP
among Tsimane is BMI (standardized estimate = 0.178, 0.170,
respectively). The magnitude of the effect, however, is not very
Table 1. CVD risk factors for Tsimane population, presented as prevalence (%) of high risk, and mean absolute level, for metabolic
and cardiovascular risk factors and indicators of infection and inflammation.
Body size / lipids / lifestyle Inflammation Pressure
Prevalence of High Risk (%) + (standard error)
Age group BMI Trig Chol HDL LDL Cig. Pack Yrs CRP WBC ESR Hyper- tension (%)
$30 $200 .240 ,40 $160 $25 $3 $10800 .20 or 13 (Stage I/II)
40–49 3.1 15.5 0.0 59.7 0.0 0.0 49.0 21.5 74.9 1.3 0.0
(0.2) (0.4) (0.0) (0.5) (0.0) (0.0) (0.1) (0.0) (0.0) (0.0) (0.0)
50–59 8.3 12.0 0.0 68.1 0.0 0.0 45.1 15.0 87.6 3.7 1.9
(0.3) (0.3) (0.0) (0.5) (0.0) (0.0) (0.1) (0.0) (0.0) (0.0) (0.0)
60–69 2.3 13.3 0.0 57.7 0.0 0.0 60.0 11.9 88.5 6.8 1.1
(0.1) (0.3) (0.0) (0.5) (0.0) (0.0) (0.1) (0.0) (0.0) (0.0) (0.0)
70+ 1.9 3.8 0.0 68.2 0.0 0.0 53.8 11.5 92.0 15.7 7.8
(0.1) (0.2) (0.0) (0.5) (0.0) (0.0) (0.1) (0.0) (0.0) (0.1) (0.0)
Mean level + (standard error)
Age group BMI Trig Chol HDL LDL Cig. Pack Yrs CRP Mean/
median
WBC ESR SBP DBP
40–49 23.9 137 144 37 80 0.4 9.9/2.7 8,968 30.1 111 68
(0.2) (8) (3) (1) (2) (0.1) (2.0) (177) (1.4) (1) (1)
50–59 24.4 142 144 37 79 0.4 6.8/2.7 8,244 38.1 115 71
(0.4) (11) (4) (1) (4) (0.1) (1.7) (251) (2.3) (1) (1)
60–69 23.2 116 136 37 76 0.7 7.2/4.0 8,218 38.6 118 70
(0.3) (15) (4) (1) (3) (0.2) (1.5) (241) (2.7) (2) (1)
70+ 22.1 121 134 35 72 0.5 15.1/3.4 8,074 47.1 121 70
(0.4) (8) (5) (2) (3) (0.2) (6.1) (296) (3.9) (3) (2)
N = 477 203 203 172 170 463 205 480 436 472
Note: Triglycerides and LDL are based on non-fasting samples for Tsimane (a 6+ hours fasting sample was used for US). Units for variables are the following:
triglycerides, cholesterol, HDL and LDL (mg/dL), BMI (kg/m2), cigarette pack years (# cigarette packs smoked per day, where 1 pack-year is equal to smoking 1 pack per
day for 1 year), CRP (mg/L), WBC (cells/mm3), ESR (mm/hr), SBP and DBP (mm Hg). For ESR, 20 is cutoff for women and 13 for men. Hypertension prevalence refers to
140#SBP,160 and/or 90#DBP,100 (Stage I) and SBP$160 and/or DBP$100.
doi:10.1371/journal.pone.0006590.t001
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large: an increase in BMI by 5 kg/m2 increases SBP by 4 mm
and DBP by 3 mm (Table 5). High total cholesterol and
triglycerides are associated with high SBP and DBP, and LDL
marginally predicts higher DBP. Similar patterns for these
variables are found in the U.S., with smaller BMI and triglyceride
effects. In the U.S., CRP significantly associates with higher SBP,
and DBP when CRP values $10 mg/L are eliminated
(b= 0.026, p,0.001).
Contrary to expectations, higher WBC and ESR associate with
lower SBP and DBP among Tsimane, and CRP is not significant in
the analyses. Restricting CRP,10 mg/L in the multiple regres-
sions in Table 5, however, makes CRP a significant negative
predictor of systolic pressure among Tsimane (b=20.728,
p = 0.026, n = 210), while in the U.S., CRP is a positive predictor
of SBP (b= 0.579, p,0.001). Cigarette smoking among Tsimane
and U.S. shows results contrary to standard prediction: higher
tobacco consumption is associated with lower SBP and DBP
(Table 5), but smoking loses significance among Tsimane in the
multiple regression in Table 4.
Discussion
Despite their high levels of inflammation, we find no evidence of
advanced atherosclerosis among Tsimane adults. This is consistent
with subjective clinical evaluation of arterial hardening: only 3 out
of 570 individuals aged 40+ showed signs of augmented tension in
the radial and humeral arteries. The presence of mild hyperten-
sion in older adults is, however, consistent with some age-related
arterial stiffening. Tsimane show several clinical indicators for
CVD: high blood CRP, low HDL and moderately elevated
triglycerides, which are established risk factors in well-nourished
populations. Tsimane diet includes salt in acculturated villages,
and Tsimane consume moderate amounts of alcohol in the form of
fermented manioc and maize. Nevertheless, we found little
evidence for the most common risk conditions of atherosclerosis
and CVD: no PAD and little hypertension. These results are
consistent with reports of low CVD among traditional foraging
and small-scale farming populations [22,25]. Hypertension and
CVD increase upon greater adoption of a western lifestyle [31].
Figure 3. Comparison of cardiovascular disease risk factors among Tsimane and United States adults. Mean levels of (A) C-reactive
protein (CRP, mg/L), (B) white blood cell (WBC) count (cells/mm3), (C) body mass index (BMI,kg/m2), (D) total and HDL cholesterol (mg/dL). Total
cholesterol correlates strongly with low-density lipoprotein (LDL) among both Tsimane (r = .82, p,.0001) and US (r = .91, p,.0001), and with
triglycerides (Tsimane: r = .48, p,.0001; US: r = .43, p,.0001), and so are not illustrated here. See Table 6 for further details.
doi:10.1371/journal.pone.0006590.g003
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Though body mass, total cholesterol, and triglycerides predict
higher blood pressure among Tsimane, the magnitude of these
separate effects is small, and combined do not put Tsimane at high
risk. Cholesterol and triglyceride elevations of 30 mg/dL coupled
with 15 kg weight gain and 20% body fat percentage increase
together add ,6 mm SBP and 5 mm DBP.
We propose several possible hypotheses to explain the low
atherosclerosis and CVD prevalence among Tsimane, and other
traditional foraging and horticultural populations living under similar
conditions. The combination of low LDL and high physical exertion
is a common feature in many of these populations. The Tsimane diet
contains wild game and fish, is low in saturated fat, and high in
potassium (K). Plantains provide ,1,500 mg K/day. Low BMI and
LDL, and sparse tobacco consumption may be protective factors
trumping the risk factors of atherosclerosis and CVD. Oxidized LDL
is implicated in inflammatory cascades leading to endothelial
dysfunction, plaque maturation and rupture; therefore some argue
that atherosclerosis and CVD are avoidable when LDL is maintained
,70 mg/dL [15]. The Tsimane LDL profile is favorable though only
34% of Tsimane adults age 40+ have LDL below 70. Mean BP and
ABI, however, do not differ among those above this LDL cutoff. With
low HDL and moderate triglyceride levels, Tsimane have a healthy
but ‘‘normal’’ mean total cholesterol to HDL ratio of 4.0 and an LDL
to HDL ratio of 2.3 (for adults age 40+).
The physically demanding Tsimane lifestyle may be central for
maintaining healthy metabolism and favorable body mass, blood
lipids and cardiorespiratory health. Subsistence hunting, fishing and
slash and burn farming require extensive daily physical activity,
consistent with high VO2max values found using a variation of the
Harvard Step Test on a subsample. Using equations of total energy
expenditure with body weights and physical activity levels (PALs) for
Tsimane and relatively sedentary U.S. adults [32], we estimate that
Tsimane men and women age 40–49 expend 850 and 450 kcals/
day more, respectively, in physical activity than U.S. adults. To
achieve mean Tsimane adult BMI, U.S. adults would need to
expend 200–300 kcals/day above current levels. Two-thirds of U.S.
adults age 18+ never engage in vigorous leisure-time physical
activities lasting 10 minutes or more per week, and only 25%
engaged in such activity 3+ times per week [33]. Only 15% of U.S.
adults engage in moderate-to-vigorous physical activity for 30
minutes or more per day as recommended by the CDC/ACSM and
stated in the Healthy People 2010 objective. A recent study using an
accelerometer rather than self-report showed that ,5% of U.S.
adults met this criterion [34]; in contrast, Tsimane adults are
physically active most days of their lives.
These results are consistent with evidence for the cardioprotec-
tive value of exercise. Exercise reduces oxidative load in muscle,
levels of inflammatory cytokines, SBP, macrophage-rich fat and
improves insulin sensitivity [10]. Exercise associates with a
favorable CVD risk profile independently of leanness [35].
Individuals with high cardio-fitness based on resting and maximal
heart rate and VO2max show the lowest heart disease risk [36,37].
Table 2. CVD risk factors for US population (based on NHANES 1999–2004), presented as prevalence (%) of high risk, and mean
absolute level, for metabolic and cardiovascular risk factors and indicators of infection and inflammation.
Body size / lipids / lifestyle Inflammation Pressure
Prevalence of High Risk (%) + (standard error)
Age group BMI Trig Chol HDL LDL Cig. Pack Yrs CRP WBC$ Hyper- Tension (%)
$30 $200 .240 ,40 $160 $25 $3 10800 (Stage I/II)
40–49 33.9 17.8 19.1 21.4 15.2 16.3 36.3 5.7 12.7 3.0
(1.3) (1.6) (1.1) (1.0) (1.6) (1.1) (1.2) (0.5) (1.0) (0.5)
50–59 35.1 23.4 22.5 19.9 17.5 24.7 41.2 5.5 17.1 5.8
(1.6) (2.0) (1.2) (1.3) (1.6) (1.0) (1.5) (0.6) (1.1) (0.7)
60–69 38.2 26.3 22.7 19.5 16.8 32.0 45.6 4.7 23.6 11.7
(1.0) (1.7) (1.0) (1.0) (1.4) (1.1) (1.5) (0.6) (1.2) (1.0)
70+ 25.7 19.0 18.9 17.0 12.4 25.3 43.3 4.3 29.3 23.7
(1.2) (1.5) (0.8) (0.9) (1.1) (0.8) (1.2) (0.4) (1.0) (1.3)
Mean level + (standard error)
Age group BMI Trig Chol HDL LDL Cig. Pack Yrs CRP WBC SBP DBP
40–49 29 159 (7.1) 208 52 125 9.6 4.1/2.0 7196 121 76
(0.2) (1.3) (0.5) (1.4) (0.5) (0.2) (60.7) (0.5) (0.3)
50–59 29 174 214 53 128 15.1 4.6/2.4 7082 127 76
(0.2) (8.3) (1.2) (0.5) (1.6) (0.6) (0.2) (76.9) (0.6) (0.4)
60–69 29 162 214 53 128 20.3 5.2/2.7 7032 135 72
(0.1) (3.5) (1.1) (0.5) (1.7) (0.8) (0.2) (64.3) (0.6) (0.4)
70+ 27 151 208 55 120 17.1 5.52.6 7227 144 65
(0.1) (2.4) (0.9) (0.5) (1.1) (0.6) (0.2) (57.1) (0.8) (0.5)
N = 8761 3871 8564 8562 3818 8641 8620 8744 8619
Note: Triglycerides and LDL are based on 6+ hours fasting sample for US (a non-fasting sample was used for Tsimane). Units for variables are the following: triglycerides,
cholesterol, HDL and LDL (mg/dL), BMI (kg/m2), cigarette pack years (# cigarette packs smoked per day, where 1 pack-year is equal to smoking 1 pack per day for 1
year), CRP (mg/L), WBC (cells/mm3), ESR (mm/hr), SBP and DBP (mm Hg). For ESR, 20 is cutoff for women and 13 for men. Hypertension prevalence refers to
140#SBP,160 and/or 90#DBP,100 (Stage I) and SBP$160 and/or DBP$100.
doi:10.1371/journal.pone.0006590.t002
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Table 3. Regression of ABI on typical risk factors and infectious disease indicators for Tsimane and US adults, 40+.
Tsimane United States
Variables beta std err R2 N beta std err R2 N
Baseline model:
Sex (ref = female) 0.052*** 0.009 0.145 258 20.041*** 0.003 0.095 7571
Age 0.008* 0.004 0.004** 0.001
Age2 0.000* ,.001 0.000 0.000
All analyses below control for sex, age and age2:
Total cholesterol (mg/dL) ,0.001 0.000 0.17 127 ,0.001+ 0.000 0.098 7219
Triglycerides (mg/dL) ,0.001 0.000 0.171 127 ,0.001+ 0.000 0.087 3343
estimated LDL (mg/dL) 0.001 0.000 0.135 110 ,0.001+ 0.000 0.083 3209
HDL (mg/dL) 20.001 0.001 0.126 110 ,0.001+ 0.000 0.097 7218
Body Mass Index (kg/m2) 20.001 0.001 0.141 255 ,0.001+ 0.000 0.093 7467
CRP (mg/L) 20.004 0.004 0.165 129 20.001 0.003 0.105 7261
WBC count (#/mm3) 0.000 0.000 0.163 232 ,0.001 0.000 0.107 7353
ESR (mm/hr) 20.005+ 0.003 0.173 234 N/A
Cigarette pack-years ,.001 0.002 0.145 257 20.001 0.000 0.120 7163
Systolic BP (mmHg) 20.001 0.000 0.154 258 20.001 0.000 0.125 7360
Diastolic BP (mmHg) 20.001** 0.000 0.175 258 ,0.001+ 0.000 0.097 7360
+p,.1.
*p,.05.
**p,.01.
***p,.001.
doi:10.1371/journal.pone.0006590.t003
Table 4. Multiple regression analyses of ABI, SBP and DBP among Tsimane and US.
TSIMANE ABI (n=126), R2 = 0.178 SBP (n =260), R2 =0.176 DBP (n=260), R2 =0.084
Variable Beta s.e. beta s.e. beta s.e.
Intercept 0.825*** 0.162 69.703*** 6.864 43.965*** 5.213
Male (reference = female) 0.052*** 0.014 3.211* 1.475 0.692 1.121
Age 0.010+ 0.005 0.302*** 0.052 0.123*** 0.039
Age2 ,2.001* ,.001 – – – –
BMI ,2.001 0.002 0.904*** 0.236 0.595*** 0.179
CRP (mg/L) 20.000 0.000 20.016 0.040 0.012 0.030
Total cholesterol ,.001 ,.001 0.035 0.025 0.026 0.019
Cigarette Pack-Years 0.003 0.010 21.023 0.638 20.555 0.484
UNITED STATES ABI (n=6746), R2 = 0.130 SBP (n =7476), R2 = 0.214 DBP (n=7476), R2 = 0.132
Variable Beta s.e. beta s.e. beta s.e.
Intercept 1.057*** 0.039 74.674*** 5.773 39.646*** 3.951
Male (reference = female) 20.046*** 0.004 1.088 0.651 22.414*** 0.371
Age 0.007*** 0.001 0.521* 0.199 1.214*** 0.143
Age2 0.000*** 0.000 0.002 0.002 20.013*** 0.001
BMI 0.000 0.000 0.383*** 0.048 0.113*** 0.030
CRP (mg/L) 20.001*** 0.000 0.018 0.032 20.022 0.026
Total cholesterol 0.000** 0.000 0.038*** 0.007 0.027*** 0.005
Cigarette Pack-Years 20.001*** 0.000 20.035** 0.012 20.040*** 0.007
+p,.1.
*p,.05.
**p,.01.
***p,.001.
doi:10.1371/journal.pone.0006590.t004
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Even Sumo wrestlers, despite intentional obesity (BMI.35;.25%
body fat), have normal blood lipid levels during training periods,
but then suffer from premature morbidity and mortality after
retiring in their mid230’s [38]. Industrialization and automation
of manual labor have diminished physical activity in most
occupations such that much physical activity in the 20th century
and beyond comes from sports and leisure. Even prior to entering
the workforce, physical activity is extremely low among US
adolescents [34].
Several alternative explanations may also be responsible for the
low CVD risk profile of Tsimane, and merit future investigation.
Tsimane and other Amerindians should be comprehensively
investigated for distinct inflammation profiles due to genetic
variability in loci affecting expression of CRP [39], apolipoprotein-
E [40], mannose-binding lectin (MBL) [41], NR4A nuclear
receptor family [42], interleukine-6 (IL-6) [43], IL-1 [44], and
toll-like receptor 4 [45]. These reflect the extent to which Tsimane
exhibit pro- or anti-inflammatory preconditions. Amerindians also
show distinct human leukocyte antigen (HLA) expression at
various MHC loci compared with other populations that show
evidence of overdominant selection [46]. Although HLA-DR
expression in macrophages and T-cells has been linked to plaque
eruption and erosion [47], it is an open question whether allelic
variation is of clinical significance. Other genetic contributions
involve the processes by which inflammation and arterial damage
result in acute coronary events. Plaque stability, disruption,
erosion and thrombogenicity may be impacted by genes affecting
interferon-a, collagen content and smooth muscle density in the
fibrous cap [48], inflammatory infiltration of the cap, lipid
composition of the atheromatous core and extracellular matrix
(e.g. soft cholesterol esters vs. hard crystalline cholesterol), and
both mechanical and hemodynamic forces that shear apart
plaques. Genetic differences affecting metalloproteinase expression
(e.g. collagenases, gelatinases, stromelysins and matrilysin) may
also be important, as these have been described as degrading all
components of the extracellular matrix and can therefore also
impact plaque disruption [49]. Genetics and diet (e.g. flavonol-rich
citrus fruits) may also influence platelet aggregation, coagulation
and fibrinolysis, which affects blood flow and thrombus formation
at the site of disrupted plaques [50]. Genes affecting monocyte
Table 5. Regression of blood pressure on typical risk factors and infectious disease indicators for Tsimane and US adults, 20+.
Systolic BP Diastolic BP
N beta std err R2 beta std err R2
TSIMANE: Baseline model
Male (reference = female) 1262 15.500*** 1.910 0.131 2.920* 1.430 0.048
Age 0.335*** 0.034 0.132*** 0.025
Sex*age 20.248*** 0.047 20.024 0.035
US: Baseline model
Male (reference = female) 13399 220.600*** 0.964 0.294 23.880*** 0.811 0.015
Age 0.373*** 0.018 20.016 0.012
Sex*age 0.393*** 0.022 0.015 0.017
TSIMANE: All analyses below control for sex and age:
Total cholesterol (mg/dL) 383 0.036+ 0.019 0.135 0.043** 0.015 0.048
Triglycerides (mg/dL) 383 0.014+ 0.008 0.135 0.012* 0.006 0.038
estimated LDL (mg/dL) 331 0.041 0.029 0.114 0.041+ 0.023 0.033
HDL (mg/dL) 331 20.026 0.071 0.108 0.064 0.056 0.026
Body Mass Index (BMI kg/m2) 1257 0.782*** 0.116 0.144 0.534*** 0.086 0.076
CRP (mg/L) 386 20.005 0.028 0.126 20.136 0.222 0.027
WBC count (#/mm3) 1000 0.000 0.000 0.114 0.000* 0.000 0.036
ESR (mm/hr) 1005 20.059*** 0.018 0.123 20.055*** 0.013 0.05
Mean Cigarette Pack-Years 788 20.789* 0.361 0.099 20.481 0.264 0.041
UNITED STATES: All analyses below control for sex and age:
Total cholesterol (mg/dL) 12641 0.027*** 0.005 0.27 0.041*** 0.004 0.034
Triglycerides (mg/dL) 5758 0.003 0.002 0.259 0.005** 0.002 0.023
estimated LDL (mg/dL) 5566 0.013+ 0.007 0.263 0.044*** 0.006 0.034
HDL (mg/dL) 12640 20.012 0.014 0.267 20.012 0.012 0.016
Body Mass Index (BMI kg/m2) 13035 0.417*** 0.034 0.284 0.270*** 0.022 0.031
CRP (mg/dL) 12705 0.081** 0.022 0.263 0.006 0.016 0.015
WBC count (#/mm3) 12844 0.000*** 0.000 0.268 0.000*** 0.000 0.019
Mean Cigarette Pack Yrs 12430 20.055*** 0.011 0.270 20.030*** 0.006 0.017
+p,.1.
*p,.05.
**p,.01.
***p,.001.
doi:10.1371/journal.pone.0006590.t005
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recruitment [e.g. CD14 receptor polymorphisms] [51], lipid
transport [e.g., cholesteryl ester transport protein (CETP)] [52],
lipid oxidation, and modulation of the inflammatory response to
oxidized lipids may also help explain differences in susceptibility of
populations to developing atherosclerosis [53].
One preliminary attempt to assess the implications of genetic
differences between Tsimane and other populations is to consider
atherosclerosis and CVD risk among Amerindians in the U.S. A
study among 13 North Amerindian groups revealed a low rate of
PAD (5.3%) among adults aged 45–74, little difference in PAD
prevalence among the groups, and significant predictive effects of
LDL, BMI, cigarette pack-years and fibrinogen [54]. Thus, while
PAD is on the low end among North Amerindians, PAD is
associated with the same risk factors as those in other populations.
Most importantly, CRP levels among North Amerindians are
higher than in other U.S. populations (median 3.2 mg/L even
after removing the 16% who had CRP.10 mg/L), and predict
incident CVD [55]. Despite similar PAD rates and lower LDL
levels than national averages, a longitudinal cohort study of CVD
among North American Indians has shown that North Amerin-
dians have higher rates of CVD than other U.S. populations, and
that standard risk factors (e.g. hypertension, LDL, HDL, BMI) are
predictive of CVD [56]. Their high rates of CRP and CVD are
likely due to the high prevalence of diabetes, renal disease and
obesity; hyperglycemia impedes endothelial function and produces
glycation end products that support myocardial dysfunction [57].
Another unexplored potential explanation highlights the
hypothesized cardioprotective effects of chronic helminthic
infection. Polarized Th-2 immune activation associated with
helminthic infection modifies cytokine profiles, whereby anti-
inflammatory IL-4, IL-10 and IL-13 protect vessel walls from
oxidized LDL-induced monocyte injury in the endothelium, and
downregulate fibrinogen synthesis [58]. Th-2 activation may also
modulate responses to heat shock proteins, Chlamydia pneumonia,
and cytomegalovirus, each of which has been tentatively linked to
atherosclerosis [59]. Finally, helminthes may modulate host lipid
metabolism, and may be responsible for lower blood cholesterol
levels in parasitized humans [60]. Indeed, total and HDL
cholesterol varied inversely with several infectious markers such
as sedimentation rate, IgE and eosinophil count among Tsimane
adults [61].
Conclusion
Though our characterization of arterial disease is provisional
pending ultrasonographic studies, our study provides evidence that
chronic low-grade inflammation in the absence of several other
risk factors is not a determinant of CVD in a subsistence
population. Inflammation and infection may not accelerate
arterial degeneration in the context of restricted caloric intake,
parasitism, and daily physical activity that maintains low BMI. We
observed low levels of atherosclerosis and associated CVD among
Tsimane, suggesting that these conditions may have been rare
throughout pre-industrial human history. However, as indigenous
populations like the Tsimane rapidly acculturate to western
lifestyles, rates of CVD among older adults may rise considerably.
Transitioning populations exhibiting western lifestyles but rela-
tively high pathogen load are likely to suffer the double burden of
chronic and infectious disease morbidity and mortality [62,63].
Materials and Methods
Ethics Statement
Informed consent was obtained for all protocols at three levels:
1) Gran Consejo Tsimane, the local Tsimane government organiza-
tion that represents Tsimane interests and oversees all projects, 2)
community officials and participants in village meetings, and 3)
individual consent during medical visits and before each
procedure. After explanation of a formal protocol by bilingual
Tsimane assistants, consent forms were signed for literate
participants, and verbal approval with fingerprint signature given
for non-literate participants. Our consent procedures have been
approved by the Institutional Review Boards at the Univ. of New
Mexico, Univ. of California-Santa Barbara and Univ. of S.
California.
Tsimane
Data were collected during annual medical exams of the
Tsimane Health and Life History Project co-directed by MG and
HK (www.unm.edu/,tsimane). Table 6 provides summary
information on the sample population. Volunteers aged 40+ in
15 villages were sampled for ABI, blood pressure and anthro-
pometry (2006 census population: 2,324 individuals; 350 were
40+, final sample n= 259, 133 or 52% male; 05–12/2007). Blood
pressure was recorded from a larger sample of volunteers aged 20+
in 25 villages (eligible population 3,482; 1,298 are 20+; n= 1,262,
50% male; 11/2005–12/2007).
In-field blood analysis of nonfasting venous samples provided
estimates of WBC and ESR. Blood measures exist for 234 ABI and
1,000 BP samples. CRP, total cholesterol, HDL and triglycerides
were analyzed separately on a subset of serum samples by TriCore
Laboratories (Albuquerque, NM). ABI exists for .110 of the 203
(age 40+), and blood pressure for 383 of the 427 (age 20+) samples
with blood lipids, CRP and antibodies. Non-fasting LDL is
estimated using the Friedewald formula (total cholesterol – HDL –
triglycerides/5). CRP, ESR, and WBC are biomarkers of
inflammation and infection.
Physicians measured ABI after training by HK and MG
according to standard protocol by the American Heart Associa-
tion. The patient lies supine with feet uncovered while brachial
and ankle systolic pressure measurements are made using a
SummitDoppler L150 ultrasound machine. Systolic pressure is
first measured in the posterior and anterior tibial arteries and the
higher of these is selected as the ankle measurement for each foot.
The cuffs are inflated on the ankle to roughly 30 mm Hg above
the systolic pressure, then followed by a slow release until the first
audible sound of systolic pressure is heard. Systolic pressure is then
measured in each arm and the highest is chosen as the brachial
pressure. The ratio of the left and right ankle pressures to the
brachial pressure is the left and right ABI. ABI ,0.9 indicates
PAD. ABI between 0.5 and 0.9 corresponds to intermittent
claudication in the lower limbs, whereas values ,0.5 are
associated with more severe symptoms such as resting pain, severe
occlusion and critical ischemia. ABI values .1.3 suggest
calcification of arterial walls and noncompressible vessels, and
are therefore also symptomatic of severe PAD.
Systolic (SBP) and diastolic (DBP) pressure were measured
during each visit with a Welch Allyn Tycos Aneroid 5090
sphygmomanometer and Littman stethoscope. The systolic
brachial pressure using the Doppler highly correlates with
aneuroidal SBP (r = 0.896, p,0.0001). Cumulative experience
smoking cigarettes was measured in cigarette pack years based on
interviews. One pack year is equal to a pack of cigarettes smoked
per day for one year. Bolivian physicians using bilingual Tsimane
assistants diagnosed illnesses and trauma presented by patients on
annual visits since 09/2002. Diagnoses from the International
Classification of Disease (ICD-10) are grouped into gastrointesti-
nal, respiratory, and other infections, over the two most recent
exams 10/2005–12/2007.
Arterial Aging among Tsimane
PLoS ONE | www.plosone.org 9 August 2009 | Volume 4 | Issue 8 | e6590
Age estimation
Age estimates are derived from demographic interviews
conducted with all individuals aged 18+ (n = 1,098) and from
missionary records. Years of birth were assigned based on
methodologies employed by researchers among the !Kung [64],
Ache [65] and Hadza [66]. These include using known ages from
written records, relative age lists, dated events, photo comparisons
of people with known ages and cross-checking of information from
independent interviews of kin. For example, Catholic missionaries
have recorded the dates of 1,110 births among the Tsimane since
1952, many of the deaths occurring during the same period, and
age estimates for an additional 120 individuals who were baptized
as small children or as young adults during the early 1950’s. In
constructing relative age lists, multiple informants were used for
each five year age grouping of individuals and inconsistencies were
investigated and resolved. The photo comparison method used a
sample of seventy photos of individuals with known ages. For older
individuals, fifty photos of men and women from ages 50 through
75 were used. Each of these methods provides a roughly
independent age estimate. When all estimates yield a date of
birth within a 3-year range, the average was used unless one or
two estimates were judged to be superior to the others. Further
details are given in [1].
United States
Tsimane health status was compared with NHANES data for
the years 1999 to 2004 (N = 7,571 for adults age 40+, N = 14,213
for adults age 20+). The NHANES monitors the health and
nutrition of a representative sample of the American noninstitu-
tionalized population. Methods have been widely published and so
are only briefly summarized here.
Lipid indicators include total, LDL and HDL cholesterol and
triglycerides. Triglycerides and LDL were measured for approx-
imately half of the sample that fasted for at least 6 hours. Total
and HDL cholesterol and triglyceries were assayed using the
Hitachi 704/717/912 Analyzer, Roche Diagnostics. Fasting LDL
cholesterol was calculated using the Friedewald equation. CRP
was determined by the latex-enhanced Behring Nephelometer.
White blood cell differentials were determined using the Beckman
CoulterH MAXM.
ABI was measured among the 40+ sample (N = 7,571) by
trained technicians. People who had amputations, excessive
obesity, or other conditions that inhibited examination were
excluded. The procedure was the same as described for the
Tsimane. Systolic and diastolic blood pressure was measured by
physicians using a stethoscope and sphygmomanometer (Bauma-
nometerH with a CalibratedH V-LokH cuff, Latex Inflation Bulb,
and an Air-FloH Control Valve). SBP and DBP values are the
average of three individual readings.
Analysis
Multiple linear regression (PROC REG in SAS 9.1) was used
for continuous values of ABI and blood pressure, as a function of
demographic variables, risk factors and disease markers. Each risk
factor is included separately in a baseline model that controls for
sex, age and age2 for ABI, and sex, age and sex*age for BP. These
results are reported in Tables 3 and 5. Table 4 reports multiple
regressions of ABI and BP that include BMI, CRP, cholesterol and
cigarette smoking.
Post-hoc power analysis for multiple regression assuming a 0.05
alpha level was performed to assess whether the absence of
significant effects in the Tsimane analyses was due to small sample
size. Given the observed R2, number of predictors and sample size,
most regressions show power above 92%. Even considering the
analysis of HDL on ABI (Table 3), where the sample size and R2
were lowest, power was still 89.6%. Only in the regressions of
diastolic BP (Table 5), where R2,0.08, did power reach as low as
70% (for HDL). The only analyses of Tsimane DBP that did not
reveal statistically significant effects, however, also were not
significant in the U.S. analyses, where power was 100%.
Table 6. Sample characteristics for key study variables in analyses of ankle-brachial index (ABI) and blood pressure (BP).
Variable Tsimane United States (NHANES)
40+ ABI sample 20+ BP sample 40+ ABI sample 20+ BP sample
Mean N Mean N Mean N Mean N
Sex (%) 51.6 258 50.8 809 51.7 7571 51.6 13399
Age (yrs) 53.1 258 37.6 1604 56.2 7571 46.1 13399
Height (cm) 156.8 257 156.1 1280 168.7 7479 169.0 13137
Weight (kg) 62.2 257 58.8 1280 80.8 7530 80.2 13149
BMI (kg/m2) 25.2 256 23.7 1266 28.3 7467 28.0 13035
Systolic BP 113.2 258 110.6 1262 128.7 7360 123.6 13399
Diastolic BP 71.1 258 67.4 1263 73.4 7360 71.7 13399
ABI 1.13 258 1.13 242 1.13 7571 1.13 7360
CRP (mg/L) 8.47 129 9.35 430 4.4 7260 4.2 12705
median 2.33 2.64 2.30 2.10
Total Chol (mg/dL) 146.5 127 137.6 427 210.7 7219 202.8 12641
HDL (mg/dL) 38.1 110 36.7 369 53.2 7218 52.2 12640
LDL (mg/dL) 80.6 108 74.8 366 126.1 3209 121.2 5566
Triglyceride (mg/dL) 134.9 127 129.8 427 162.2 3343 148.2 5758
Cigarette pack-yrs 0.4 257 0.4 800 14.5 7162 10.3 12429
doi:10.1371/journal.pone.0006590.t006
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